Related Experiment Videos
Dilated cardiomyopathy with 3-methylglutaconic aciduria
J M Draaisma1, I C van Kesteren, O Daniëls
1Department of Pediatric Cardiology, University Hospital, St. Radboud, Nijmegen, The Netherlands.
Pediatric Cardiology
|March 1, 1994
Summary
This case study presents an infant with dilated cardiomyopathy and 3-methylglutaconic aciduria, highlighting a rare co-occurrence. The review examines the limited literature on this combined condition in infants.
Area of Science:
- Pediatric Cardiology
- Metabolic Disorders
- Genetics
Background:
- Dilated cardiomyopathy is a significant cause of heart failure in infants.
- 3-methylglutaconic aciduria represents a group of rare inherited metabolic disorders affecting fatty acid oxidation.
Observation:
- A case of an infant presenting with concurrent dilated cardiomyopathy and 3-methylglutaconic aciduria is detailed.
- Clinical presentation and diagnostic findings are described for this unique patient.
Findings:
- The co-existence of dilated cardiomyopathy and 3-methylglutaconic aciduria in an infant is a rare clinical finding.
- Literature review reveals limited data on this specific combined condition.
Implications:
- This case underscores the importance of considering metabolic investigations in infants with unexplained cardiomyopathy.
- Further research is needed to understand the pathophysiology and management of this rare comorbidity.